Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.
- DOI
- 10.1021/acs.jmedchem.6c00743
- Published
- 2026 Jul 23
- Container
- Journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acs.jmedchem.6c00743,
title = {Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.},
author = {Acharyya RK and Bai L and Zhou H and Wu D and Wang M and Metwally H and McEachern D and Wang M and Wen B and Sun D and Wang S},
year = {2026},
journal = {Journal of medicinal chemistry},
doi = {10.1021/acs.jmedchem.6c00743},
url = {https://doi.org/10.1021/acs.jmedchem.6c00743}
}RIS
TY - JOUR TI - Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration. AU - Acharyya RK AU - Bai L AU - Zhou H AU - Wu D AU - Wang M AU - Metwally H AU - McEachern D AU - Wang M AU - Wen B AU - Sun D AU - Wang S PY - 2026 JO - Journal of medicinal chemistry DO - 10.1021/acs.jmedchem.6c00743 UR - https://doi.org/10.1021/acs.jmedchem.6c00743 ER -
APA
RK, A., L, B., H, Z., D, W., M, W., H, M., D, M., M, W., B, W., D, S., & S, W. (2026). Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.. Journal of medicinal chemistry. https://doi.org/10.1021/acs.jmedchem.6c00743
Source records
- pubmed · retrieved 2026-09-27T07:09:12.740Z